SCHEMBL256040

SCHEMBL256040

CC/C=C/c1ccc(Br)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.38
GPR183 P32249 1/20 0.36
NFE2L2 Q16236 4/20 0.35
PYCR1 P32322 1/20 0.34
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
ALOX12 P18054 1/20 0.34
RAB9A P51151 1/20 0.34
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP1B1 Q16678 1/20 0.33
FLT3 P36888 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
KDM1A O60341 2/20 0.33
KDM1B Q8NB78 1/20 0.33
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14416453 1.00 DGAT1 (0.38) DGAT1GPR183NFE2L2PYCR1ALDH1A1
SCHEMBL8291060 1.00 DGAT1 (0.38) DGAT1GPR183NFE2L2PYCR1ALDH1A1
SCHEMBL14416449 0.85 SMN1; SMN2 (0.38) DGAT1GPR183NFE2L2FLT3LMNA
SCHEMBL8956869 0.81 GPR183 (0.39) DGAT1GPR183NFE2L2ALDH1A1NPC1
SCHEMBL2089425 0.81 GPR183 (0.39) DGAT1GPR183NFE2L2NPC1RAB9A
SCHEMBL8956862 0.81 GPR183 (0.39) DGAT1GPR183NFE2L2ALDH1A1NPC1
SCHEMBL2089427 0.81 GPR183 (0.39) DGAT1GPR183NFE2L2NPC1RAB9A
SCHEMBL256688 0.81 NFE2L2 (0.55) NFE2L2RAB9ACYP1A1CYP1B1PTGS1
SCHEMBL23888923 0.81 CYP1A1 (0.37) GPR183NFE2L2ALDH1A1CYP1A1CYP1A2
SCHEMBL2091129 0.80 GPR183 (0.39) DGAT1GPR183NFE2L2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones BAYER CROPSCIENCE AG (DE) 2012-06-21 US disclosed
WO-2012028578-A1 SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES BAYER CROPSCIENCE AG (DE) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones DHPS, FDPS, DPYD DGAT1 1972/4885GPR183 4734/4885NFE2L2 255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.